{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:45:01Z","timestamp":1790624701896,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["33CS30_177499"],"award-info":[{"award-number":["33CS30_177499"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SHCS","award":["324730B_179571"],"award-info":[{"award-number":["324730B_179571"]}]},{"name":"SHCS","award":["310030_141067"],"award-info":[{"award-number":["310030_141067"]}]},{"name":"SHCS","award":["324730_207957"],"award-info":[{"award-number":["324730_207957"]}]},{"name":"SHCS","award":["BSSGI0_155851"],"award-info":[{"award-number":["BSSGI0_155851"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Next-generation sequencing (NGS) is gradually replacing Sanger sequencing (SS) as the primary method for HIV genotypic resistance testing. However, there are limited systematic data on comparability of these methods in a clinical setting for the presence of low-abundance drug resistance mutations (DRMs) and their dependency on the variant-calling thresholds.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To compare the HIV-DRMs detected by SS and NGS, we included participants enrolled in the Swiss HIV Cohort Study (SHCS) with SS and NGS sequences available with sample collection dates \u22647 days apart. We tested for the presence of HIV-DRMs and compared the agreement between SS and NGS at different variant-calling thresholds.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 594 pairs of SS and NGS from 527 SHCS participants. Males accounted for 80.5% of the participants, 76.3% were ART naive at sample collection and 78.1% of the sequences were subtype B. Overall, we observed a good agreement (Cohen\u2019s kappa &amp;gt;0.80) for HIV-DRMs for variant-calling thresholds \u22655%. We observed an increase in low-abundance HIV-DRMs detected at lower thresholds [28\/417 (6.7%) at 10%\u201325% to 293\/812 (36.1%) at 1%\u20132% threshold]. However, such low-abundance HIV-DRMs were overrepresented in ART-naive participants and were in most cases not detected in previously sampled sequences suggesting high sequencing error for thresholds &amp;lt;3%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We found high concordance between SS and NGS but also a substantial number of low-abundance HIV-DRMs detected only by NGS at lower variant-calling thresholds. Our findings suggest that a substantial fraction of the low-abundance HIV-DRMs detected at thresholds &amp;lt;3% may represent sequencing errors and hence should not be overinterpreted in clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jac\/dkac430","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T12:09:53Z","timestamp":1675512593000},"page":"656-664","source":"Crossref","is-referenced-by-count":20,"title":["Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1"],"prefix":"10.1093","volume":"78","author":[{"given":"Suraj","family":"Balakrishna","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"},{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Loosli","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"},{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zaheri","sequence":"additional","affiliation":[{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"},{"name":"Swiss National Center for Retroviruses, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Frischknecht","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Huber","sequence":"additional","affiliation":[{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"},{"name":"Swiss National Center for Retroviruses, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4638-1940","authenticated-orcid":false,"given":"Katharina","family":"Kusejko","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"},{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Yerly","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, University Hospital Geneva, University of Geneva , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Leuzinger","sequence":"additional","affiliation":[{"name":"Clinical Virology Division, Laboratory Medicine, University Hospital Basel , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Perreau","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, University Hospital Lausanne, University of Lausanne , Lausanne , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-4639","authenticated-orcid":false,"given":"Alban","family":"Ramette","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9847-8226","authenticated-orcid":false,"given":"Chris","family":"Wymant","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Fraser","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford , Oxford , UK"},{"name":"Nuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kellam","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Faculty of Medicine, Imperial College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Gall","sequence":"additional","affiliation":[{"name":"Excellence in Life Sciences (EMBO) , Heidelberg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0883-0423","authenticated-orcid":false,"given":"Hans H","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Stoeckle","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andri","family":"Rauch","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0933-7833","authenticated-orcid":false,"given":"Matthias","family":"Cavassini","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Lausanne University Hospital, University of Lausanne , Lausanne , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Regional Hospital Lugano , Lugano , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Notter","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen , St Gallen , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Calmy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University Hospital Geneva, University of Geneva , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-6723","authenticated-orcid":false,"given":"Huldrych F","family":"G\u00fcnthard","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"},{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin J","family":"Metzner","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"},{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9220-8348","authenticated-orcid":false,"given":"Roger D","family":"Kouyos","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"},{"name":"Institute of Medical Virology, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/QAD.0000000000001335","article-title":"Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population","volume":"31","author":"Gueler","year":"2017","journal-title":"AIDS"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2023030208094632400_","first-page":"77","article-title":"European recommendations for the clinical use of HIV drug resistance testing: 2011 update","volume":"13","author":"Vandamme","year":"2011","journal-title":"AIDS Rev"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-134-6-200103200-00008","article-title":"Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness","volume":"134","author":"Weinstein","year":"2001","journal-title":"Ann Intern Med"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cid\/ciy463","article-title":"Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society\u2014USA panel","volume":"68","author":"G\u00fcnthard","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/365671a0","article-title":"Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing","volume":"365","author":"Larder","year":"1993","journal-title":"Nature"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00105-18","article-title":"Comparison of an in vitro diagnostic next-generation sequencing assay with Sanger sequencing for HIV-1 genotypic resistance testing","volume":"56","author":"Tzou","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/JCM.37.7.2291-2296.1999","article-title":"Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase","volume":"37","author":"Schuurman","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00329","article-title":"Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data","volume":"3","author":"Beerenwinkel","year":"2012","journal-title":"Front Microbiol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1128\/AAC.01490-15","article-title":"HIV Drug resistance testing by high-multiplex \u201cwide\u201d sequencing on the MiSeq instrument","volume":"59","author":"Lapointe","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/COH.0000000000000737","article-title":"Technologies for HIV-1 drug resistance testing: inventory and needs","volume":"17","author":"Metzner","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/jac\/dkx232","article-title":"RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients","volume":"72","author":"Alidjinou","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010176","article-title":"Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children","volume":"97","author":"Fokam","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/jmv.24872","article-title":"Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and Sanger sequencing using clinical samples","volume":"89","author":"Trabaud","year":"2017","journal-title":"J Med Virol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"21846","DOI":"10.7448\/IAS.20.1.21846","article-title":"Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000\u20132014","volume":"20","author":"Moscona","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/jmv.26582","article-title":"Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next-generation sequencing in HIV-positive patients","volume":"93","author":"Tekin","year":"2021","journal-title":"J Med Virol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1038\/s41598-018-25888-6","article-title":"Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing","volume":"8","author":"Telele","year":"2018","journal-title":"Sci Rep"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2018.08.001","article-title":"Evaluating the accuracy and sensitivity of detecting minority HIV-1 populations by Illumina next-generation sequencing","volume":"261","author":"Kireev","year":"2018","journal-title":"J Virol Methods"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/v12070694","article-title":"Multi-laboratory comparison of next-generation to Sanger-based sequencing for HIV-1 drug resistance genotyping","volume":"12","author":"Parkin","year":"2020","journal-title":"Viruses"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1038\/s41598-019-45328-3","article-title":"A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance","volume":"9","author":"Taylor","year":"2019","journal-title":"Sci Rep"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ije\/dyab141","article-title":"Cohort profile update: the Swiss HIV Cohort Study (SHCS)","volume":"51","author":"Scherrer","year":"2022","journal-title":"Int J Epidemiol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/cid\/cir725","article-title":"Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection","volume":"53","author":"Rieder","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2023030208094632400_","author":"Schmutz","year":"2021"},{"key":"2023030208094632400_","first-page":"866","article-title":"Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?","volume":"72","author":"Kletenkov","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/QAD.0b013e3282f0b685","article-title":"Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey","volume":"21","author":"Yerly","year":"2007","journal-title":"AIDS"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gku537","article-title":"Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations","volume":"42","author":"Giallonardo","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1128\/JCM.01516-12","article-title":"Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes","volume":"50","author":"Gall","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/infdis\/jiz094","article-title":"Viral diversity based on next-generation sequencing of HIV-1 provides precise estimates of infection recency and time since infection","volume":"220","author":"Carlisle","year":"2019","journal-title":"J Infect Dis"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1038\/s41467-020-19198-7","article-title":"Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART","volume":"11","author":"Wan","year":"2020","journal-title":"Nat Commun"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/jiac166","article-title":"A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV cohort study","volume":"226","author":"Chaudron","year":"2022","journal-title":"J Infect Dis"},{"key":"2023030208094632400_","article-title":"Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe","volume":"15","author":"Blanquart","year":"2017","journal-title":"PLoS Biol"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2016.08.004","article-title":"From clinical sample to complete genome: comparing methods for the extraction of HIV-1 RNA for high-throughput deep sequencing","volume":"239","author":"Cornelissen","year":"2017","journal-title":"Virus Res"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/v13030404","article-title":"A novel high throughput, parallel infection assay for determining the replication capacities of 346 primary HIV-1 isolates of the Zurich primary HIV-1 infection study in primary cells","volume":"13","author":"Rindler","year":"2021","journal-title":"Viruses"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"key":"2023030208094632400_","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2020"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","article-title":"Ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R","volume":"35","author":"Paradis","year":"2019","journal-title":"Bioinformatics"},{"key":"2023030208094632400_","volume-title":"psych: Procedures for Personality and Psychological Research","author":"Revelle","year":"2021"},{"key":"2023030208094632400_","author":"Canty","year":"; 2021"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2015.04.022","article-title":"Performance assessment of the Illumina massively parallel sequencing platform for deep sequencing analysis of viral minority variants","volume":"221","author":"Thys","year":"2015","journal-title":"J Virol Methods"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2016.11.008","article-title":"Minvar: a rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing","volume":"240","author":"Huber","year":"2017","journal-title":"J Virol Methods"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/pathogens10030264","article-title":"HIV drug resistance mutations detection by next-generation sequencing during antiretroviral therapy interruption in China","volume":"10","author":"Li","year":"2021","journal-title":"Pathogens"},{"key":"2023030208094632400_","first-page":"662","article-title":"Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure","volume":"201","author":"Paredes","year":"2010","journal-title":"J Infect Dis"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case\u2013control study using centralized ultrasensitive 454 pyrosequencing","volume":"70","author":"Cozzi-Lepri","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00038-16","article-title":"Low-frequency drug resistance in HIV-infected Ugandans on antiretroviral treatment is associated with regimen failure","volume":"60","author":"Kyeyune","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2023030208094632400_","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/infdis\/jiz650","article-title":"Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact","volume":"221","author":"Mbunkah","year":"2020","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/3\/656\/49376449\/dkac430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/3\/656\/49376449\/dkac430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T17:46:17Z","timestamp":1678988777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/78\/3\/656\/7026052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2,4]]},"published-print":{"date-parts":[[2023,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac430","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,2]]},"published":{"date-parts":[[2023,2,4]]}}}